CompletedNot Applicable

Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis

United States35 participantsStarted 2007-12

Plain-language summary

In cooperation with Merck \& Co, Inc. we will identify and form a database of 35 patients who have developed osteochemonecrosis of the jaws related to oral bisphosphonate use. We will study the triggers, associated medical conditions and medications, location of the lesion(s), and patient outcomes.

Who can participate

Age range30 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Exposed bone in the oral cavity of greater than 6-8 weeks duration unresponsive to therapy Exclusion Criteria: * Pregnant patients * Patients less than 30 yrs of age or greater than 90 yrs of age * Mentally incompetent individuals

What they're measuring

establish complete database and publish descriptive paper

Timeframe: 2 years

Trial details

NCT IDNCT00601068

SponsorUniversity of Florida

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2011-07

View on ClinicalTrials.gov More Osteonecrosis trials